Kirk A. Davis - 12 Aug 2024 Form 4 Insider Report for HARTE HANKS INC (HHS)

Role: Chief Executive Officer
Signature: /s/ Robert Wyman, Attorney-in-fact for Kirk Davis
Issuer symbol: HHS
Transactions as of: 12 Aug 2024
Net transactions value: +$49,999
Form type: 4
Filing time: 12 Aug 2024, 14:32:46 UTC
Previous filing: 13 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HHS	Common Stock	Purchase	$49,574	+7,082	+32%	$7.00	29,413	12 Aug 2024	Direct	F1
transaction	HHS	Common Stock	Purchase	$425	+61	+0.21%	$6.96	29,474	12 Aug 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	HHS	Option to buy Common Shares						240,000	12 Aug 2024	Common Stock	240,000	$5.59	NQ stock options granted and held by Harte Hanks, Inc. until exercised.	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Participant purchased common shares.
F2	NQ stock options granted on August 14, 2023 under the Harte Hanks, Inc. 2023 Inducement Equity Incentive Plan. The options vest and become exercisable as to 1/3rd of the underlying shares on each of the first three anniversaries of June 19, 2023.